HomeNewsTrendsJN.1 subvariant: Karnataka issues ‘mask up’ advisory, increases Covid-19 testing

JN.1 subvariant: Karnataka issues ‘mask up’ advisory, increases Covid-19 testing

The Karnataka government has issued an advisory asking the elderly and vulnerable to mask up. They are also strongly advised to steer clear of closed and poorly-ventilated spaces.

December 20, 2023 / 10:38 IST
Story continues below Advertisement
Covid drill India
Covid-19 advisory: The Karnataka government is asking the elderly and vulnerable to wear masks in public

Anticipating a potential surge in Covid-19 cases due to the emergence of the JN.1 subvariant in the neighbouring states of Kerala and Tamil Nadu, the Karnataka government has issued an advisory asking the elderly and vulnerable to mask up. The state has also stepped up testing and Whole Genome Sequencing (WGS) of confirmed cases, according to Swarajya magazine.

The World Health Organization (WHO) on Tuesday classified the JN.1 coronavirus strain as a "variant of interest", but said it did not pose much threat to public health. JN.1 was previously classified as a variant of interest as a part of its parent lineage BA.2.86.

Story continues below Advertisement

On Tuesday, the Karnataka government circulated an advisory based on recommendations made by the state’s Covid-19 technical advisory committee. Here is what the Karnataka advisory to the general public entails:

The Karnataka government is urging individuals aged 60 and above, especially those with comorbidities (kidney, heart and liver ailments) to wear masks when outdoors.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show